Lodoli, Claudio
Rosati, Andrea
Foschi, Nazario
Santullo, Francesco
Abatini, Carlo
El Halabieh, Miriam Attalla
Gallotta, Valerio
Fagotti, Anna
Pacelli, Fabio
Article History
Received: 29 October 2024
Accepted: 20 February 2025
First Online: 15 April 2025
Disclosure
: Anna Fagotti has undertaken relevant financial activities outside the submitted work for AstraZeneca/MSD, Fondazione Internazionale Menarini, GlaxoSmithKline, Oncoinvent AS, and Covidien/Medtronic. Claudio Lodoli, Andrea Rosati, Nazario Foschi, Francesco Santullo, Carlo Abatini, Miriam Attalla El Halabieh, Valerio Gallotta, and Fabio Pacelli have no conflicts of interest to declare that may be relevant to the contents of this article.